Insider Trading › DGX › Insiders
QUEST DIAGNOSTICS INC
DGX·NYSE·
United States·Insider activity
United States·Insider activity$228.39
-3.83 (-1.65%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
DGX
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
DGXS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, DGX insiders filed 0 purchases ($0) and 7 sales ($11.9M) on the open market, by 4 insiders. Newest filing Sep 3, 2026 (1 month ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by DGX insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$11.9MSales · 180 days
575Open-market transactions on record
4Insiders filing · 180 days
Purchases (code P) and sales (code S) of DGX common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
575 on record · newest trade first · the newest 300 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Davis J. E.CEO and President · Director | Sale | −10.0K | $242.72 | $2.4M | 122.4Kdirect | Sep 1, 2026 | Sep 3, 2026 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −6,237 | $243.63 | $1.5M | 38.0Kdirect | Aug 28, 2026 | Aug 31, 2026 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −430 | $244.51 | $105K | 37.6Kdirect | Aug 28, 2026 | Aug 31, 2026 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −16.0K | $242.88 | $3.9M | 44.2Kdirect | Aug 28, 2026 | Aug 31, 2026 | Form 4 ↗ |
| DELANEY MARK ESVP & Chief Commercial Officer | Sale | −1,600 | $235.18 | $376K | 10.3Kdirect | Jul 28, 2026 | Jul 29, 2026 | Form 4 ↗ |
| KUPPUSAMY KARTHIKSVP, Clinical Solutions | Sale | −8,147 | $200.00 | $1.6M | 13.5Kdirect | Jun 4, 2026 | Jun 8, 2026 | Form 4 ↗ |
| Davis J. E.CEO and President · Director | Sale | −10.0K | $194.14 | $1.9M | 132.4Kdirect | Jun 1, 2026 | Jun 2, 2026 | Form 4 ↗ |
| Doherty Catherine T.EVP, Regional Businesses | Sale | −5,558 | $206.21 | $1.1M | 67.1Kdirect | Mar 5, 2026 | Mar 6, 2026 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −3,878 | $206.21 | $800K | 37.6Kdirect | Mar 5, 2026 | Mar 6, 2026 | Form 4 ↗ |
| Plewman PatrickSVP for Diagnostic Services | Sale | −2,855 | $206.21 | $589K | 15.2Kdirect | Mar 5, 2026 | Mar 6, 2026 | Form 4 ↗ |
| KUPPUSAMY KARTHIKSVP, Clinical Solutions | Sale | −2,628 | $204.86 | $538K | 13.4Kdirect | Mar 4, 2026 | Mar 6, 2026 | Form 4 ↗ |
| Doherty Catherine T.EVP, Regional Businesses | Sale | −632 | $207.73 | $131K | 67.1Kdirect | Mar 3, 2026 | Mar 4, 2026 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −526 | $207.73 | $109K | 37.6Kdirect | Mar 3, 2026 | Mar 4, 2026 | Form 4 ↗ |
| Plewman PatrickSVP for Diagnostic Services | Sale | −410 | $207.73 | $85K | 15.2Kdirect | Mar 3, 2026 | Mar 4, 2026 | Form 4 ↗ |
| Davis J. E.CEO and President · Director | Sale | −10.0K | $212.52 | $2.1M | 117.2Kdirect | Mar 2, 2026 | Mar 4, 2026 | Form 4 ↗ |
| Doherty Catherine T.EVP, Regional Businesses | Sale | −1,433 | $204.83 | $294K | 68.4Kdirect | Feb 19, 2026 | Feb 20, 2026 | Form 4 ↗ |
| Plewman PatrickSVP for Diagnostic Services | Sale | −958 | $204.83 | $196K | 15.8Kdirect | Feb 19, 2026 | Feb 20, 2026 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −1,111 | $204.83 | $228K | 38.4Kdirect | Feb 19, 2026 | Feb 20, 2026 | Form 4 ↗ |
| Doherty Catherine T.EVP, Regional Businesses | Sale | −351 | $209.10 | $73K | 68.1Kdirect | Feb 13, 2026 | Feb 17, 2026 | Form 4 ↗ |
| Doherty Catherine T.EVP, Regional Businesses | Sale | −1,619 | $208.21 | $337K | 68.4Kdirect | Feb 13, 2026 | Feb 17, 2026 | Form 4 ↗ |
| Doherty Catherine T.EVP, Regional Businesses | Sale | −3,500 | $207.08 | $725K | 70.0Kdirect | Feb 13, 2026 | Feb 17, 2026 | Form 4 ↗ |
| Doherty Catherine T.EVP, Regional Businesses | Sale | −10.1K | $206.37 | $2.1M | 73.5Kdirect | Feb 13, 2026 | Feb 17, 2026 | Form 4 ↗ |
| Doherty Catherine T.EVP, Regional Businesses | Sale | −10.6K | $205.21 | $2.2M | 83.7Kdirect | Feb 13, 2026 | Feb 17, 2026 | Form 4 ↗ |
| Plewman PatrickSVP for Diagnostic Services | Sale | −5,662 | $204.00 | $1.2M | 15.4Kdirect | Feb 10, 2026 | Feb 12, 2026 | Form 4 ↗ |
| Davis J. E.CEO and President · Director | Sale | −4,747 | $192.97 | $916K | 120.5Kdirect | Nov 25, 2025 | Nov 28, 2025 | Form 4 ↗ |
| Davis J. E.CEO and President · Director | Sale | −41.0K | $192.27 | $7.9M | 125.2Kdirect | Nov 25, 2025 | Nov 28, 2025 | Form 4 ↗ |
| Davis J. E.CEO and President · Director | Sale | −9,342 | $191.59 | $1.8M | 166.2Kdirect | Nov 25, 2025 | Nov 28, 2025 | Form 4 ↗ |
| Gregg Vicky BDirector | Sale | −1,250 | $191.76 | $240K | 17.0Kdirect | Nov 25, 2025 | Nov 28, 2025 | Form 4 ↗ |
| DELANEY MARK ESVP & Chief Commercial Officer | Sale | −7,946 | $187.35 | $1.5M | 7,530direct | Nov 18, 2025 | Nov 20, 2025 | Form 4 ↗ |
| PFEIFFER GARY MDirector | Sale | −1,482 | $182.40 | $270K | 29.4Kdirect | Oct 22, 2025 | Oct 24, 2025 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −144 | $188.66 | $27K | 38.1Kdirect | Sep 26, 2025 | Sep 30, 2025 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −83 | $187.22 | $16K | 38.3Kdirect | Sep 26, 2025 | Sep 30, 2025 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −175 | $187.02 | $33K | 38.1Kdirect | Sep 24, 2025 | Sep 25, 2025 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −28.3K | $187.12 | $5.3M | 38.1Kdirect | Sep 23, 2025 | Sep 25, 2025 | Form 4 ↗ |
| Plewman PatrickSVP for Diagnostic Services | Sale | −1,975 | $185.00 | $365K | 15.3Kdirect | Aug 21, 2025 | Aug 25, 2025 | Form 4 ↗ |
| Plewman PatrickSVP for Diagnostic Services | Sale | −4,532 | $183.00 | $829K | 17.2Kdirect | Aug 19, 2025 | Aug 21, 2025 | Form 4 ↗ |
| Plewman PatrickSVP for Diagnostic Services | Sale | −1,975 | $180.00 | $356K | 17.2Kdirect | Aug 15, 2025 | Aug 19, 2025 | Form 4 ↗ |
| Plewman PatrickSVP for Diagnostic Services | Sale | −1,975 | $175.00 | $346K | 19.2Kdirect | Aug 6, 2025 | Aug 8, 2025 | Form 4 ↗ |
| Plewman PatrickSVP for Diagnostic Services | Sale | −3,560 | $175.00 | $623K | 21.2Kdirect | Aug 6, 2025 | Aug 8, 2025 | Form 4 ↗ |
| KUPPUSAMY KARTHIKSVP, Clinical Solutions | Sale | −2,210 | $170.00 | $376K | 8,450direct | Jul 31, 2025 | Aug 1, 2025 | Form 4 ↗ |
| KUPPUSAMY KARTHIKSVP, Clinical Solutions | Sale | −5,224 | $167.40 | $874K | 10.7Kdirect | Jul 30, 2025 | Aug 1, 2025 | Form 4 ↗ |
| KUPPUSAMY KARTHIKSVP, Clinical Solutions | Sale | −3,045 | $167.40 | $510K | 10.7Kdirect | Jul 30, 2025 | Aug 1, 2025 | Form 4 ↗ |
| DELANEY MARK ESVP & Chief Commercial Officer | Sale | −874 | $175.31 | $153K | 7,498direct | May 13, 2025 | May 14, 2025 | Form 4 ↗ |
| DELANEY MARK ESVP & Chief Commercial Officer | Sale | −874 | $175.72 | $154K | 8,372direct | May 12, 2025 | May 14, 2025 | Form 4 ↗ |
| Davis J. E.CEO and President · Director | Sale | −453 | $169.63 | $77K | 127.6Kdirect | Apr 2, 2025 | Apr 4, 2025 | Form 4 ↗ |
| Davis J. E.CEO and President · Director | Sale | −902 | $168.79 | $152K | 128.1Kdirect | Apr 2, 2025 | Apr 4, 2025 | Form 4 ↗ |
| Davis J. E.CEO and President · Director | Sale | −1,493 | $167.88 | $251K | 129.0Kdirect | Apr 2, 2025 | Apr 4, 2025 | Form 4 ↗ |
| Davis J. E.CEO and President · Director | Sale | −267 | $169.60 | $45K | 130.5Kdirect | Apr 2, 2025 | Apr 4, 2025 | Form 4 ↗ |
| Davis J. E.CEO and President · Director | Sale | −584 | $168.70 | $99K | 130.7Kdirect | Apr 2, 2025 | Apr 4, 2025 | Form 4 ↗ |
| Davis J. E.CEO and President · Director | Sale | −750 | $167.86 | $126K | 131.3Kdirect | Apr 2, 2025 | Apr 4, 2025 | Form 4 ↗ |
| Davis J. E.CEO and President · Director | Sale | −2,493 | $169.57 | $423K | 132.1Kdirect | Apr 2, 2025 | Apr 4, 2025 | Form 4 ↗ |
| Davis J. E.CEO and President · Director | Sale | −5,900 | $168.66 | $995K | 134.6Kdirect | Apr 2, 2025 | Apr 4, 2025 | Form 4 ↗ |
| Davis J. E.CEO and President · Director | Sale | −6,950 | $167.86 | $1.2M | 140.5Kdirect | Apr 2, 2025 | Apr 4, 2025 | Form 4 ↗ |
| Davis J. E.CEO and President · Director | Sale | −2,764 | $169.56 | $469K | 147.4Kdirect | Apr 2, 2025 | Apr 4, 2025 | Form 4 ↗ |
| Davis J. E.CEO and President · Director | Sale | −4,905 | $168.72 | $828K | 150.2Kdirect | Apr 2, 2025 | Apr 4, 2025 | Form 4 ↗ |
| Davis J. E.CEO and President · Director | Sale | −7,249 | $167.86 | $1.2M | 155.1Kdirect | Apr 2, 2025 | Apr 4, 2025 | Form 4 ↗ |
| Davis J. E.CEO and President · Director | Sale | −704 | $169.63 | $119K | 162.3Kdirect | Apr 2, 2025 | Apr 4, 2025 | Form 4 ↗ |
| Davis J. E.CEO and President · Director | Sale | −1,411 | $168.76 | $238K | 163.0Kdirect | Apr 2, 2025 | Apr 4, 2025 | Form 4 ↗ |
| Davis J. E.CEO and President · Director | Sale | −2,366 | $168.03 | $398K | 164.4Kdirect | Apr 2, 2025 | Apr 4, 2025 | Form 4 ↗ |
| KUPPUSAMY KARTHIKSVP, Clinical Solutions | Sale | −2,555 | $170.00 | $434K | 10.6Kdirect | Apr 2, 2025 | Apr 4, 2025 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −4,643 | $170.00 | $789K | 38.1Kdirect | Mar 17, 2025 | Mar 19, 2025 | Form 4 ↗ |
| Doherty Catherine T.EVP, Regional Businesses | Sale | −5,370 | $174.13 | $935K | 68.1Kdirect | Mar 5, 2025 | Mar 7, 2025 | Form 4 ↗ |
| Doherty Catherine T.EVP, Regional Businesses | Sale | −716 | $175.79 | $126K | 68.1Kdirect | Mar 4, 2025 | Mar 5, 2025 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −592 | $175.79 | $104K | 38.1Kdirect | Mar 4, 2025 | Mar 5, 2025 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −528 | $172.61 | $91K | 39.0Kdirect | Feb 27, 2025 | Feb 28, 2025 | Form 4 ↗ |
| Doherty Catherine T.EVP, Regional Businesses | Sale | −824 | $172.61 | $142K | 69.2Kdirect | Feb 27, 2025 | Feb 28, 2025 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −604 | $170.99 | $103K | 39.8Kdirect | Feb 20, 2025 | Feb 21, 2025 | Form 4 ↗ |
| Doherty Catherine T.EVP, Regional Businesses | Sale | −899 | $170.99 | $154K | 70.5Kdirect | Feb 20, 2025 | Feb 21, 2025 | Form 4 ↗ |
| Plewman PatrickSVP for Diagnostic Services | Sale | −320 | $169.71 | $54K | 18.1Kdirect | Feb 19, 2025 | Feb 21, 2025 | Form 4 ↗ |
| Doherty Catherine T.EVP, Regional Businesses | Sale | −535 | $169.71 | $91K | 71.4Kdirect | Feb 19, 2025 | Feb 21, 2025 | Form 4 ↗ |
| Gregg Vicky BDirector | Sale | −1,250 | $164.57 | $206K | 16.9Kdirect | Feb 5, 2025 | Feb 7, 2025 | Form 4 ↗ |
| DELANEY MARK ESVP & Chief Commercial Officer | Sale | −403 | $164.30 | $66K | 4,624direct | Feb 5, 2025 | Feb 7, 2025 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −32.1K | $163.15 | $5.2M | 38.5Kdirect | Nov 29, 2024 | Dec 2, 2024 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −3,009 | $162.26 | $488K | 70.6Kdirect | Nov 29, 2024 | Dec 2, 2024 | Form 4 ↗ |
| Doherty Catherine T.EVP, Regional Businesses | Sale | −28.3K | $163.13 | $4.6M | 68.4Kdirect | Nov 27, 2024 | Dec 2, 2024 | Form 4 ↗ |
| Doherty Catherine T.EVP, Regional Businesses | Sale | −4,803 | $162.14 | $779K | 96.7Kdirect | Nov 27, 2024 | Dec 2, 2024 | Form 4 ↗ |
| DEPPE MICHAEL JSVP, Corp. Controller & CAO | Sale | −5,189 | $154.74 | $803K | 34.9Kdirect | Nov 6, 2024 | Nov 7, 2024 | Form 4 ↗ |
| DEPPE MICHAEL JSVP, Corp. Controller & CAO | Sale | −2,331 | $154.03 | $359K | 40.1Kdirect | Nov 6, 2024 | Nov 7, 2024 | Form 4 ↗ |
| DEPPE MICHAEL JSVP, Corp. Controller & CAO | Sale | −2,600 | $152.71 | $397K | 42.5Kdirect | Nov 6, 2024 | Nov 7, 2024 | Form 4 ↗ |
| DEPPE MICHAEL JSVP, Corp. Controller & CAO | Sale | −4,135 | $154.74 | $640K | 45.1Kdirect | Nov 6, 2024 | Nov 7, 2024 | Form 4 ↗ |
| DEPPE MICHAEL JSVP, Corp. Controller & CAO | Sale | −2,400 | $153.98 | $370K | 49.2Kdirect | Nov 6, 2024 | Nov 7, 2024 | Form 4 ↗ |
| DEPPE MICHAEL JSVP, Corp. Controller & CAO | Sale | −2,100 | $152.70 | $321K | 51.6Kdirect | Nov 6, 2024 | Nov 7, 2024 | Form 4 ↗ |
| KUPPUSAMY KARTHIKSVP, Clinical Solutions | Sale | −1,775 | $156.92 | $279K | 9,734direct | Oct 28, 2024 | Oct 30, 2024 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −32.6K | $154.97 | $5.0M | 38.5Kdirect | Aug 29, 2024 | Sep 3, 2024 | Form 4 ↗ |
| KUPPUSAMY KARTHIKSVP, Clinical Solutions | Sale | −1,990 | $153.26 | $305K | 11.5Kdirect | Aug 28, 2024 | Aug 29, 2024 | Form 4 ↗ |
| DELANEY MARK ESVP & Chief Commercial Officer | Sale | −420 | $143.08 | $60K | 5,019direct | Jul 24, 2024 | Jul 26, 2024 | Form 4 ↗ |
| KUPPUSAMY KARTHIKSVP, Clinical Solutions | Sale | −1,760 | $140.00 | $246K | 13.4Kdirect | Apr 29, 2024 | May 1, 2024 | Form 4 ↗ |
| Doherty Catherine T.EVP, Regional Businesses | Sale | −1,187 | $125.88 | $149K | 68.4Kdirect | Feb 29, 2024 | Mar 1, 2024 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −5,611 | $125.88 | $706K | 38.5Kdirect | Feb 29, 2024 | Mar 1, 2024 | Form 4 ↗ |
| Doherty Catherine T.EVP, Regional Businesses | Sale | −5,557 | $126.57 | $703K | 69.6Kdirect | Feb 28, 2024 | Mar 1, 2024 | Form 4 ↗ |
| Gregg Vicky BDirector | Sale | −2,500 | $126.64 | $317K | 16.3Kdirect | Feb 23, 2024 | Feb 23, 2024 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −661 | $126.14 | $83K | 40.2Kdirect | Feb 22, 2024 | Feb 23, 2024 | Form 4 ↗ |
| Doherty Catherine T.EVP, Regional Businesses | Sale | −821 | $126.14 | $104K | 70.8Kdirect | Feb 22, 2024 | Feb 23, 2024 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −4,754 | $140.55 | $668K | 38.5Kdirect | Mar 7, 2023 | Mar 8, 2023 | Form 4 ↗ |
| Doherty Catherine T.SVP, Regional Businesses | Sale | −5,307 | $140.55 | $746K | 67.8Kdirect | Mar 7, 2023 | Mar 8, 2023 | Form 4 ↗ |
| Doherty Catherine T.SVP, Regional Businesses | Sale | −717 | $140.63 | $101K | 67.8Kdirect | Mar 3, 2023 | Mar 6, 2023 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −593 | $138.54 | $82K | 38.5Kdirect | Mar 2, 2023 | Mar 3, 2023 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −1,415 | $141.42 | $200K | 39.4Kdirect | Feb 24, 2023 | Feb 27, 2023 | Form 4 ↗ |
| Doherty Catherine T.SVP, Regional Businesses | Sale | −1,690 | $141.42 | $239K | 68.9Kdirect | Feb 24, 2023 | Feb 27, 2023 | Form 4 ↗ |
| RING TIMOTHY MDirector | Sale | −2,025 | $152.50 | $309K | 24.1Kdirect | Dec 1, 2022 | Dec 5, 2022 | Form 4 ↗ |
| Doherty Catherine T.SVP, Regional Businesses | Sale | −23.4K | $149.37 | $3.5M | 67.7Kdirect | Nov 28, 2022 | Nov 29, 2022 | Form 4 ↗ |
| Doherty Catherine T.SVP, Regional Businesses | Sale | −17.4K | $148.92 | $2.6M | 91.1Kdirect | Nov 28, 2022 | Nov 29, 2022 | Form 4 ↗ |
| RING TIMOTHY MDirector | Sale | −2,000 | $144.06 | $288K | 24.1Kdirect | Nov 1, 2022 | Nov 2, 2022 | Form 4 ↗ |
| DEPPE MICHAEL JVP, Corp. Controller & CAO | Sale | −15.5K | $145.00 | $2.2M | 32.0Kdirect | Oct 26, 2022 | Oct 27, 2022 | Form 4 ↗ |
| RING TIMOTHY MDirector | Sale | −2,000 | $123.39 | $247K | 23.9Kdirect | Oct 3, 2022 | Oct 4, 2022 | Form 4 ↗ |
| RING TIMOTHY MDirector | Sale | −2,000 | $125.02 | $250K | 23.9Kdirect | Sep 1, 2022 | Sep 6, 2022 | Form 4 ↗ |
| RING TIMOTHY MDirector | Sale | −2,000 | $136.04 | $272K | 23.9Kdirect | Aug 1, 2022 | Aug 2, 2022 | Form 4 ↗ |
| RING TIMOTHY MDirector | Sale | −2,000 | $133.47 | $267K | 23.9Kdirect | Jul 1, 2022 | Jul 5, 2022 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −900 | $142.13 | $128K | 334.8Kdirect | May 25, 2022 | May 26, 2022 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −4,131 | $141.35 | $584K | 335.7Kdirect | May 25, 2022 | May 26, 2022 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −9,823 | $140.58 | $1.4M | 339.9Kdirect | May 25, 2022 | May 26, 2022 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −651 | $142.15 | $93K | 334.8Kdirect | May 25, 2022 | May 26, 2022 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −2,565 | $141.36 | $363K | 335.5Kdirect | May 25, 2022 | May 26, 2022 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −6,821 | $140.60 | $959K | 338.0Kdirect | May 25, 2022 | May 26, 2022 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −156.3K | $140.12 | $21.9M | 334.8Kdirect | May 24, 2022 | May 25, 2022 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −126.1K | $140.12 | $17.7M | 334.8Kdirect | May 24, 2022 | May 25, 2022 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −300 | $142.24 | $43K | 334.8Kdirect | May 23, 2022 | May 25, 2022 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −1,000 | $141.51 | $142K | 335.1Kdirect | May 23, 2022 | May 25, 2022 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −41.3K | $140.12 | $5.8M | 336.1Kdirect | May 23, 2022 | May 25, 2022 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −200 | $142.26 | $28K | 334.8Kdirect | May 23, 2022 | May 25, 2022 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −800 | $141.54 | $113K | 335.0Kdirect | May 23, 2022 | May 25, 2022 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −33.9K | $140.12 | $4.7M | 335.8Kdirect | May 23, 2022 | May 25, 2022 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −50.6K | $139.97 | $7.1M | 39.2Kdirect | May 17, 2022 | May 19, 2022 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −6,228 | $135.21 | $842K | 39.2Kdirect | Mar 8, 2022 | Mar 9, 2022 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −7,032 | $135.21 | $951K | 67.7Kdirect | Mar 8, 2022 | Mar 9, 2022 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −661 | $130.00 | $86K | 39.2Kdirect | Feb 28, 2022 | Mar 2, 2022 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −2,750 | $126.26 | $347K | 64.4Kdirect | Feb 24, 2022 | Feb 28, 2022 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −1,669 | $126.26 | $211K | 37.1Kdirect | Feb 24, 2022 | Feb 28, 2022 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −14.6K | $157.53 | $2.3M | 68.7Kdirect | Nov 29, 2021 | Dec 1, 2021 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −15.9K | $156.86 | $2.5M | 83.3Kdirect | Nov 29, 2021 | Dec 1, 2021 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −3,532 | $155.77 | $550K | 99.2Kdirect | Nov 29, 2021 | Dec 1, 2021 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −3,250 | $154.79 | $503K | 102.7Kdirect | Nov 29, 2021 | Dec 1, 2021 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −300 | $153.38 | $46K | 106.0Kdirect | Nov 29, 2021 | Dec 1, 2021 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −4,193 | $141.22 | $592K | 284.4Kdirect | Jul 29, 2021 | Jul 30, 2021 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −5,300 | $140.59 | $745K | 284.4Kdirect | Jul 29, 2021 | Jul 30, 2021 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −139.8K | $140.14 | $19.6M | 284.4Kdirect | Jul 28, 2021 | Jul 30, 2021 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −32.8K | $140.01 | $4.6M | 284.4Kdirect | Jul 27, 2021 | Jul 28, 2021 | Form 4 ↗ |
| WILENSKY GAIL RDirector | Sale | −6,111 | $139.27 | $851K | 17.8Kdirect | Jul 27, 2021 | Jul 28, 2021 | Form 4 ↗ |
| WILENSKY GAIL RDirector | Sale | −6,111 | $139.32 | $851K | 17.8Kdirect | Jul 27, 2021 | Jul 28, 2021 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −5,813 | $140.03 | $814K | 284.4Kdirect | Jul 26, 2021 | Jul 28, 2021 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −8,536 | $139.96 | $1.2M | 68.7Kdirect | May 7, 2021 | May 11, 2021 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −44.9K | $137.00 | $6.2M | 40.2Kdirect | May 5, 2021 | May 7, 2021 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −5,574 | $120.47 | $671K | 40.2Kdirect | Mar 10, 2021 | Mar 11, 2021 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −801 | $115.49 | $93K | 40.2Kdirect | Feb 25, 2021 | Mar 1, 2021 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −750 | $116.95 | $88K | 41.0Kdirect | Feb 24, 2021 | Feb 25, 2021 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −438 | $116.95 | $51K | 41.7Kdirect | Feb 24, 2021 | Feb 25, 2021 | Form 4 ↗ |
| GUINAN MARKExecutive Vice President & CFO | Sale | −22.6K | $121.18 | $2.7M | 73.6Kdirect | Dec 24, 2020 | Dec 28, 2020 | Form 4 ↗ |
| GUINAN MARKExecutive Vice President & CFO | Sale | −59.2K | $120.06 | $7.1M | 96.1Kdirect | Dec 24, 2020 | Dec 28, 2020 | Form 4 ↗ |
| WILENSKY GAIL RDirector | Sale | −6,111 | $126.02 | $770K | 16.5Kdirect | Nov 24, 2020 | Nov 27, 2020 | Form 4 ↗ |
| STANZIONE DANIELDirector | Sale | −2,300 | $127.45 | $293K | 28.3Kdirect | Nov 23, 2020 | Nov 24, 2020 | Form 4 ↗ |
| STANZIONE DANIELDirector | Sale | −3,302 | $126.46 | $418K | 30.6Kdirect | Nov 23, 2020 | Nov 24, 2020 | Form 4 ↗ |
| STANZIONE DANIELDirector | Sale | −5,621 | $125.73 | $707K | 34.0Kdirect | Nov 23, 2020 | Nov 24, 2020 | Form 4 ↗ |
| DEPPE MICHAEL JVP, Corp. Controller & CAO | Sale | −4,750 | $125.00 | $594K | 25.1Kdirect | Oct 21, 2020 | Oct 23, 2020 | Form 4 ↗ |
| DEPPE MICHAEL JVP, Corp. Controller & CAO | Sale | −5,700 | $125.00 | $713K | 29.8Kdirect | Oct 21, 2020 | Oct 23, 2020 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −292.0K | $120.00 | $35.0M | 237.7Kdirect | Oct 16, 2020 | Oct 19, 2020 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −35.6K | $119.00 | $4.2M | 40.1Kdirect | Oct 14, 2020 | Oct 15, 2020 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −3,776 | $111.13 | $420K | 68.4Kdirect | Sep 2, 2020 | Sep 4, 2020 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −54.6K | $110.57 | $6.0M | 72.2Kdirect | Sep 2, 2020 | Sep 4, 2020 | Form 4 ↗ |
| GUINAN MARKExecutive Vice President & CFO | Sale | −8,524 | $118.60 | $1.0M | 73.6Kdirect | Jun 8, 2020 | Jun 10, 2020 | Form 4 ↗ |
| GUINAN MARKExecutive Vice President & CFO | Sale | −18.2K | $117.65 | $2.1M | 82.1Kdirect | Jun 8, 2020 | Jun 10, 2020 | Form 4 ↗ |
| GUINAN MARKExecutive Vice President & CFO | Sale | −45.8K | $116.81 | $5.4M | 100.3Kdirect | Jun 8, 2020 | Jun 10, 2020 | Form 4 ↗ |
| RING TIMOTHY MDirector | Sale | −11.7K | $116.60 | $1.4M | 20.5Kdirect | Jun 8, 2020 | Jun 10, 2020 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −11.7K | $112.01 | $1.3M | 237.7Kdirect | Apr 27, 2020 | Apr 28, 2020 | Form 4 ↗ |
| EGLINTON MANNER CARRIESVP, Advanced Diagnostics | Sale | −2,500 | $110.00 | $275K | 22.4Kdirect | Apr 27, 2020 | Apr 28, 2020 | Form 4 ↗ |
| EGLINTON MANNER CARRIESVP, Advanced Diagnostics | Sale | −2,500 | $112.03 | $280K | 24.9Kdirect | Apr 27, 2020 | Apr 28, 2020 | Form 4 ↗ |
| Davis J. E.EVP, General Diagnostics | Sale | −500 | $90.15 | $45K | 38.1Kdirect | Mar 16, 2020 | Mar 17, 2020 | Form 4 ↗ |
| Davis J. E.EVP, General Diagnostics | Sale | −421 | $88.53 | $37K | 38.6Kdirect | Mar 16, 2020 | Mar 17, 2020 | Form 4 ↗ |
| Davis J. E.EVP, General Diagnostics | Sale | −1,307 | $87.81 | $115K | 39.0Kdirect | Mar 16, 2020 | Mar 17, 2020 | Form 4 ↗ |
| Davis J. E.EVP, General Diagnostics | Sale | −1,085 | $86.65 | $94K | 40.3Kdirect | Mar 16, 2020 | Mar 17, 2020 | Form 4 ↗ |
| Davis J. E.EVP, General Diagnostics | Sale | −200 | $85.59 | $17K | 41.4Kdirect | Mar 16, 2020 | Mar 17, 2020 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −2,175 | $104.25 | $227K | 40.1Kdirect | Mar 11, 2020 | Mar 12, 2020 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −2,501 | $104.25 | $261K | 68.4Kdirect | Mar 11, 2020 | Mar 12, 2020 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −100 | $112.19 | $11K | 237.7Kdirect | Mar 10, 2020 | Mar 12, 2020 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −2,000 | $116.27 | $233K | 226.6Kdirect | Mar 6, 2020 | Mar 10, 2020 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −3,937 | $115.45 | $455K | 228.6Kdirect | Mar 6, 2020 | Mar 10, 2020 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −16.4K | $114.24 | $1.9M | 232.5Kdirect | Mar 6, 2020 | Mar 10, 2020 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −36.8K | $113.65 | $4.2M | 248.9Kdirect | Mar 6, 2020 | Mar 10, 2020 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, CEO and President · Director | Sale | −171.0K | $112.21 | $19.2M | 285.7Kdirect | Mar 6, 2020 | Mar 10, 2020 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −690 | $109.02 | $75K | 40.1Kdirect | Feb 27, 2020 | Feb 28, 2020 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −789 | $109.02 | $86K | 68.4Kdirect | Feb 27, 2020 | Feb 28, 2020 | Form 4 ↗ |
| Davis J. E.EVP, General Diagnostics | Sale | −1,100 | $109.02 | $120K | 38.1Kdirect | Feb 27, 2020 | Feb 28, 2020 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −321 | $111.09 | $36K | 41.4Kdirect | Feb 26, 2020 | Feb 28, 2020 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −368 | $111.09 | $41K | 70.0Kdirect | Feb 26, 2020 | Feb 28, 2020 | Form 4 ↗ |
| Davis J. E.EVP, General Diagnostics | Sale | −510 | $111.09 | $57K | 40.4Kdirect | Feb 26, 2020 | Feb 28, 2020 | Form 4 ↗ |
| Davis J. E.EVP, General Diagnostics | Sale | −598 | $112.73 | $67K | 41.5Kdirect | Feb 25, 2020 | Feb 26, 2020 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −405 | $112.73 | $46K | 70.7Kdirect | Feb 25, 2020 | Feb 26, 2020 | Form 4 ↗ |
| Davis J. E.EVP, General Diagnostics | Sale | −8,853 | $106.51 | $943K | 36.5Kdirect | Jan 2, 2020 | Jan 3, 2020 | Form 4 ↗ |
| Davis J. E.EVP, General Diagnostics | Sale | −69.0K | $105.45 | $7.3M | 45.4Kdirect | Jan 2, 2020 | Jan 3, 2020 | Form 4 ↗ |
| Davis J. E.EVP, General Diagnostics | Sale | −7,423 | $106.51 | $791K | 114.4Kdirect | Jan 2, 2020 | Jan 3, 2020 | Form 4 ↗ |
| Davis J. E.EVP, General Diagnostics | Sale | −58.3K | $105.46 | $6.1M | 121.8Kdirect | Jan 2, 2020 | Jan 3, 2020 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −500 | $107.83 | $54K | 39.5Kdirect | Nov 27, 2019 | Dec 4, 2019 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −32.2K | $107.53 | $3.5M | 40.0Kdirect | Nov 27, 2019 | Dec 4, 2019 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −11.9K | $107.15 | $1.3M | 72.2Kdirect | Nov 27, 2019 | Dec 4, 2019 | Form 4 ↗ |
| WILENSKY GAIL RDirector | Sale | −8,000 | $107.17 | $857K | 15.0Kdirect | Nov 26, 2019 | Nov 27, 2019 | Form 4 ↗ |
| DEPPE MICHAEL JVP, Corp. Controller & CAO | Sale | −5,000 | $106.00 | $530K | 23.7Kdirect | Sep 17, 2019 | Sep 19, 2019 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, President and CEO · Director | Sale | −244.6K | $100.00 | $24.5M | 213.0Kdirect | Jun 13, 2019 | Jun 17, 2019 | Form 4 ↗ |
| GUINAN MARKExecutive Vice President & CFO | Sale | −73.0K | $100.00 | $7.3M | 66.0Kdirect | Jun 13, 2019 | Jun 17, 2019 | Form 4 ↗ |
| Davis J. E.EVP, General Diagnostics | Sale | −47.6K | $95.00 | $4.5M | 36.5Kdirect | Apr 24, 2019 | Apr 26, 2019 | Form 4 ↗ |
| Davis J. E.EVP, General Diagnostics | Sale | −2,100 | $90.70 | $190K | 36.5Kdirect | Apr 8, 2019 | Apr 10, 2019 | Form 4 ↗ |
| Davis J. E.EVP, General Diagnostics | Sale | −5,900 | $90.15 | $532K | 38.6Kdirect | Apr 8, 2019 | Apr 10, 2019 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −5,890 | $90.59 | $534K | 67.5Kdirect | Apr 4, 2019 | Apr 8, 2019 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −60.5K | $90.59 | $5.5M | 73.4Kdirect | Apr 4, 2019 | Apr 8, 2019 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −3,373 | $86.81 | $293K | 39.5Kdirect | Mar 4, 2019 | Mar 5, 2019 | Form 4 ↗ |
| Cunningham EverettSVP, Commercial | Sale | −3,892 | $86.81 | $338K | 38.3Kdirect | Mar 4, 2019 | Mar 5, 2019 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −1,048 | $86.51 | $91K | 39.5Kdirect | Feb 27, 2019 | Feb 28, 2019 | Form 4 ↗ |
| Cunningham EverettSVP, Commercial | Sale | −1,144 | $86.51 | $99K | 38.3Kdirect | Feb 27, 2019 | Feb 28, 2019 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −364 | $87.06 | $32K | 40.5Kdirect | Feb 26, 2019 | Feb 28, 2019 | Form 4 ↗ |
| Cunningham EverettSVP, Commercial | Sale | −352 | $87.06 | $31K | 39.4Kdirect | Feb 26, 2019 | Feb 28, 2019 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −336 | $88.23 | $30K | 41.8Kdirect | Feb 25, 2019 | Feb 27, 2019 | Form 4 ↗ |
| Cunningham EverettSVP, Commercial | Sale | −326 | $88.23 | $29K | 40.9Kdirect | Feb 25, 2019 | Feb 27, 2019 | Form 4 ↗ |
| WILENSKY GAIL RDirector | Sale | −8,000 | $87.78 | $702K | 26.6Kdirect | Feb 22, 2019 | Feb 25, 2019 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −30.8K | $113.07 | $3.5M | 39.8Kdirect | Jul 10, 2018 | Jul 12, 2018 | Form 4 ↗ |
| Cunningham EverettSVP, Commercial | Sale | −40.3K | $112.00 | $4.5M | 38.3Kdirect | Jul 10, 2018 | Jul 12, 2018 | Form 4 ↗ |
| Cunningham EverettSVP, Commercial | Sale | −781 | $110.12 | $86K | 38.3Kdirect | Jul 2, 2018 | Jul 5, 2018 | Form 4 ↗ |
| Cunningham EverettSVP, Commercial | Sale | −7,066 | $109.63 | $775K | 38.9Kdirect | Jul 2, 2018 | Jul 5, 2018 | Form 4 ↗ |
| Cunningham EverettSVP, Commercial | Sale | −5,583 | $110.07 | $615K | 45.9Kdirect | Jul 2, 2018 | Jul 5, 2018 | Form 4 ↗ |
| Cunningham EverettSVP, Commercial | Sale | −33.3K | $109.60 | $3.7M | 51.5Kdirect | Jul 2, 2018 | Jul 5, 2018 | Form 4 ↗ |
| Cunningham EverettSVP, Commercial | Sale | −1,496 | $110.12 | $165K | 45.9Kdirect | Jul 2, 2018 | Jul 5, 2018 | Form 4 ↗ |
| Cunningham EverettSVP, Commercial | Sale | −19.8K | $109.64 | $2.2M | 47.4Kdirect | Jul 2, 2018 | Jul 5, 2018 | Form 4 ↗ |
| LEIDEN JEFFREY MDirector | Sale | −1,644 | $105.61 | $174K | 6,000direct | May 29, 2018 | May 30, 2018 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, President and CEO · Director | Sale | −168.5K | $107.00 | $18.0M | 191.1Kdirect | May 25, 2018 | May 29, 2018 | Form 4 ↗ |
| GUINAN MARKExecutive Vice President & CFO | Sale | −25.0K | $106.14 | $2.6M | 58.2Kdirect | May 25, 2018 | May 29, 2018 | Form 4 ↗ |
| GUINAN MARKExecutive Vice President & CFO | Sale | −36.6K | $105.42 | $3.9M | 83.2Kdirect | May 25, 2018 | May 29, 2018 | Form 4 ↗ |
| Cohen Jon RSVP & Group Exec. Diag. Sol. | Sale | −7,773 | $104.77 | $814K | 31.8Kdirect | Mar 8, 2018 | Mar 12, 2018 | Form 4 ↗ |
| Cohen Jon RSVP & Group Exec. Diag. Sol. | Sale | −2,800 | $104.77 | $293K | 39.5Kdirect | Mar 8, 2018 | Mar 12, 2018 | Form 4 ↗ |
| Cohen Jon RSVP & Group Exec. Diag. Sol. | Sale | −34.2K | $104.09 | $3.6M | 42.3Kdirect | Mar 8, 2018 | Mar 12, 2018 | Form 4 ↗ |
| Cohen Jon RSVP & Group Exec. Diag. Sol. | Sale | −1,300 | $104.77 | $136K | 76.5Kdirect | Mar 8, 2018 | Mar 12, 2018 | Form 4 ↗ |
| Cohen Jon RSVP & Group Exec. Diag. Sol. | Sale | −18.2K | $104.09 | $1.9M | 77.8Kdirect | Mar 8, 2018 | Mar 12, 2018 | Form 4 ↗ |
| Cohen Jon RSVP & Group Exec. Diag. Sol. | Sale | −1,427 | $104.76 | $149K | 96.0Kdirect | Mar 8, 2018 | Mar 12, 2018 | Form 4 ↗ |
| Cohen Jon RSVP & Group Exec. Diag. Sol. | Sale | −18.0K | $104.09 | $1.9M | 97.4Kdirect | Mar 8, 2018 | Mar 12, 2018 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −4,128 | $101.00 | $417K | 39.8Kdirect | Mar 5, 2018 | Mar 6, 2018 | Form 4 ↗ |
| Davis J. E.EVP, General Diagnostics | Sale | −5,122 | $101.00 | $517K | 37.1Kdirect | Mar 5, 2018 | Mar 6, 2018 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −5,556 | $101.00 | $561K | 67.9Kdirect | Mar 5, 2018 | Mar 6, 2018 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −496 | $104.99 | $52K | 39.8Kdirect | Feb 28, 2018 | Mar 1, 2018 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −572 | $104.99 | $60K | 67.9Kdirect | Feb 28, 2018 | Mar 1, 2018 | Form 4 ↗ |
| Davis J. E.EVP, General Diagnostics | Sale | −648 | $104.99 | $68K | 37.0Kdirect | Feb 28, 2018 | Mar 1, 2018 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −927 | $104.10 | $97K | 40.3Kdirect | Feb 27, 2018 | Mar 1, 2018 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −1,248 | $104.10 | $130K | 68.5Kdirect | Feb 27, 2018 | Mar 1, 2018 | Form 4 ↗ |
| Davis J. E.EVP, General Diagnostics | Sale | −1,150 | $104.10 | $120K | 37.7Kdirect | Feb 27, 2018 | Mar 1, 2018 | Form 4 ↗ |
| Klug Robert AVP, Corporate Controller | Sale | −1,157 | $103.66 | $120K | 3,903direct | Feb 26, 2018 | Feb 27, 2018 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −397 | $102.74 | $41K | 70.3Kdirect | Feb 26, 2018 | Feb 27, 2018 | Form 4 ↗ |
| Davis J. E.EVP, General Diagnostics | Sale | −494 | $102.74 | $51K | 39.7Kdirect | Feb 26, 2018 | Feb 27, 2018 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, President and CEO · Director | Sale | −106.8K | $107.00 | $11.4M | 166.1Kdirect | Jan 29, 2018 | Jan 31, 2018 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −21.3K | $104.00 | $2.2M | 69.4Kdirect | Jan 24, 2018 | Jan 26, 2018 | Form 4 ↗ |
| Davis J. E.EVP, General Diagnostics | Sale | −63.9K | $98.68 | $6.3M | 38.1Kdirect | Jan 2, 2018 | Jan 4, 2018 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, President and CEO · Director | Sale | −5,302 | $108.12 | $573K | 166.1Kdirect | Sep 12, 2017 | Sep 13, 2017 | Form 4 ↗ |
| STANZIONE DANIELDirector | Sale | −40.9K | $108.07 | $4.4M | 34.7Kdirect | Sep 11, 2017 | Sep 13, 2017 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, President and CEO · Director | Sale | −53.9K | $108.16 | $5.8M | 166.1Kdirect | Sep 11, 2017 | Sep 13, 2017 | Form 4 ↗ |
| STANZIONE DANIELDirector | Sale | −3,803 | $108.01 | $411K | 34.7Kdirect | Sep 5, 2017 | Sep 7, 2017 | Form 4 ↗ |
| RUSCKOWSKI STEPHEN HChairman, President and CEO · Director | Sale | −2,525 | $108.03 | $273K | 166.1Kdirect | Sep 5, 2017 | Sep 7, 2017 | Form 4 ↗ |
| LEIDEN JEFFREY MDirector | Sale | −296 | $106.66 | $32K | 6,000direct | Aug 4, 2017 | Aug 8, 2017 | Form 4 ↗ |
| LEIDEN JEFFREY MDirector | Sale | −1,304 | $108.73 | $142K | 6,296direct | Jul 27, 2017 | Jul 31, 2017 | Form 4 ↗ |
| Cohen Jon RSVP & Group Exec. Diag. Sol. | Sale | −2,559 | $108.13 | $277K | 73.2Kdirect | Jun 19, 2017 | Jun 21, 2017 | Form 4 ↗ |
| Cohen Jon RSVP & Group Exec. Diag. Sol. | Sale | −61.3K | $107.53 | $6.6M | 75.7Kdirect | Jun 19, 2017 | Jun 21, 2017 | Form 4 ↗ |
| Cohen Jon RSVP & Group Exec. Diag. Sol. | Sale | −1,158 | $108.14 | $125K | 137.1Kdirect | Jun 19, 2017 | Jun 21, 2017 | Form 4 ↗ |
| Cohen Jon RSVP & Group Exec. Diag. Sol. | Sale | −28.2K | $107.53 | $3.0M | 138.2Kdirect | Jun 19, 2017 | Jun 21, 2017 | Form 4 ↗ |
| Cohen Jon RSVP & Group Exec. Diag. Sol. | Sale | −336 | $108.15 | $36K | 166.4Kdirect | Jun 19, 2017 | Jun 21, 2017 | Form 4 ↗ |
| Cohen Jon RSVP & Group Exec. Diag. Sol. | Sale | −13.3K | $107.52 | $1.4M | 166.7Kdirect | Jun 19, 2017 | Jun 21, 2017 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −177 | $108.15 | $19K | 69.4Kdirect | Jun 19, 2017 | Jun 21, 2017 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −6,418 | $107.54 | $690K | 69.6Kdirect | Jun 19, 2017 | Jun 21, 2017 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −1,364 | $108.14 | $148K | 76.0Kdirect | Jun 19, 2017 | Jun 21, 2017 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −42.6K | $107.52 | $4.6M | 77.4Kdirect | Jun 19, 2017 | Jun 21, 2017 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −315 | $108.16 | $34K | 120.0Kdirect | Jun 19, 2017 | Jun 21, 2017 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −8,852 | $107.54 | $952K | 120.3Kdirect | Jun 19, 2017 | Jun 21, 2017 | Form 4 ↗ |
| BRITELL JENNE KDirector | Sale | −6,111 | $104.03 | $636K | 19.9Kindirect | Apr 24, 2017 | Apr 26, 2017 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −28.5K | $100.00 | $2.9M | 40.3Kdirect | Apr 20, 2017 | Apr 24, 2017 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −1,013 | $100.00 | $101K | 40.3Kdirect | Apr 20, 2017 | Apr 24, 2017 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −14.0K | $100.00 | $1.4M | 40.3Kdirect | Mar 16, 2017 | Mar 20, 2017 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −4,478 | $98.29 | $440K | 40.3Kdirect | Mar 3, 2017 | Mar 6, 2017 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −6,028 | $98.29 | $592K | 74.2Kdirect | Mar 3, 2017 | Mar 6, 2017 | Form 4 ↗ |
| Doherty Catherine T.SVP, Group Exec. Clin. Fran. | Sale | −1,134 | $98.25 | $111K | 80.2Kdirect | Mar 2, 2017 | Mar 6, 2017 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −470 | $97.77 | $46K | 40.3Kdirect | Mar 1, 2017 | Mar 3, 2017 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −440 | $97.39 | $43K | 41.3Kdirect | Feb 27, 2017 | Feb 28, 2017 | Form 4 ↗ |
| ZIEGLER JOHN BDirector | Sale | −2,000 | $95.51 | $191K | 16.6Kdirect | Feb 22, 2017 | Feb 24, 2017 | Form 4 ↗ |
| Doherty Catherine T.SVP, Clin. Franchise Solutions | Sale | −1,615 | $94.65 | $153K | 73.4Kdirect | Feb 15, 2017 | Feb 17, 2017 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −1,200 | $93.76 | $113K | 39.5Kdirect | Feb 13, 2017 | Feb 15, 2017 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −15.0K | $92.38 | $1.4M | 42.0Kdirect | Feb 2, 2017 | Feb 6, 2017 | Form 4 ↗ |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | −30.0K | $92.40 | $2.8M | 41.9Kdirect | Feb 2, 2017 | Feb 6, 2017 | Form 4 ↗ |
| Doherty Catherine T.SVP, Clin. Franchise Solutions | Sale | −37.4K | $90.40 | $3.4M | 76.7Kdirect | Jan 30, 2017 | Feb 1, 2017 | Form 4 ↗ |
| Doherty Catherine T.SVP, Clin. Franchise Solutions | Sale | −11.5K | $91.61 | $1.1M | 76.7Kdirect | Jan 30, 2017 | Feb 1, 2017 | Form 4 ↗ |
| Doherty Catherine T.SVP, Clin. Franchise Solutions | Sale | −31.1K | $90.42 | $2.8M | 88.2Kdirect | Jan 30, 2017 | Feb 1, 2017 | Form 4 ↗ |
| PFEIFFER GARY MDirector | Sale | −8,310 | $85.25 | $708K | 13.7Kdirect | Nov 15, 2016 | Nov 17, 2016 | Form 4 ↗ |
| PFEIFFER GARY MDirector | Sale | −6,111 | $85.18 | $521K | 22.0Kdirect | Nov 15, 2016 | Nov 17, 2016 | Form 4 ↗ |
| PFEIFFER GARY MDirector | Sale | −6,111 | $85.09 | $520K | 22.0Kdirect | Nov 15, 2016 | Nov 17, 2016 | Form 4 ↗ |
| PFEIFFER GARY MDirector | Sale | −6,111 | $85.07 | $520K | 22.0Kdirect | Nov 15, 2016 | Nov 17, 2016 | Form 4 ↗ |
| PFEIFFER GARY MDirector | Sale | −8,000 | $84.94 | $680K | 22.0Kdirect | Nov 15, 2016 | Nov 17, 2016 | Form 4 ↗ |
| PFEIFFER GARY MDirector | Sale | −8,000 | $85.01 | $680K | 22.0Kdirect | Nov 15, 2016 | Nov 17, 2016 | Form 4 ↗ |
| BRITELL JENNE KDirector | Sale | −4,000 | $84.76 | $339K | 19.9Kindirect | Aug 19, 2016 | Aug 22, 2016 | Form 4 ↗ |
| BRITELL JENNE KDirector | Sale | −4,000 | $85.20 | $341K | 19.9Kindirect | Aug 10, 2016 | Aug 11, 2016 | Form 4 ↗ |
| LEIDEN JEFFREY MDirector | Sale | −311 | $85.61 | $27K | 6,027direct | Aug 3, 2016 | Aug 4, 2016 | Form 4 ↗ |
| LEIDEN JEFFREY MDirector | Sale | −1,747 | $85.57 | $149K | 6,027direct | Aug 3, 2016 | Aug 4, 2016 | Form 4 ↗ |
| LEIDEN JEFFREY MDirector | Sale | −1,563 | $85.65 | $134K | 6,027direct | Aug 3, 2016 | Aug 4, 2016 | Form 4 ↗ |
| LEIDEN JEFFREY MDirector | Sale | −800 | $85.66 | $69K | 6,027direct | Aug 3, 2016 | Aug 4, 2016 | Form 4 ↗ |
| LEIDEN JEFFREY MDirector | Sale | −718 | $85.65 | $61K | 6,827direct | Aug 3, 2016 | Aug 4, 2016 | Form 4 ↗ |
| LEIDEN JEFFREY MDirector | Sale | −1,206 | $85.62 | $103K | 6,027direct | Aug 3, 2016 | Aug 4, 2016 | Form 4 ↗ |
| ZIEGLER JOHN BDirector | Sale | −1,000 | $84.36 | $84K | 18.6Kdirect | Jul 25, 2016 | Jul 27, 2016 | Form 4 ↗ |
| Doherty Catherine T.SVP, Clin. Franchise Solutions | Sale | −23.7K | $77.26 | $1.8M | 76.7Kdirect | May 27, 2016 | Jun 1, 2016 | Form 4 ↗ |
| Doherty Catherine T.SVP, Clin. Franchise Solutions | Sale | −23.7K | $77.27 | $1.8M | 100.4Kdirect | May 27, 2016 | Jun 1, 2016 | Form 4 ↗ |
| BRITELL JENNE KDirector | Sale | −8,000 | $75.68 | $605K | 11.7Kindirect | May 12, 2016 | May 16, 2016 | Form 4 ↗ |
| Cunningham EverettSVP, Commercial | Sale | −13.3K | $76.21 | $1.0M | 31.9Kdirect | May 9, 2016 | May 11, 2016 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →